trial

Effect of Metacognitive Therapy on Negative Symptoms: a Case Series

NCTId NCT03999112
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 8 (estimated)
Sponsored by NHS Greater Glasgow and Clyde
Primary completion 2020-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
8 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Sequential
Masking
None
Start
2020-01-22
Primary completion
2020-04
Eligibility
ALL · 18 Years

Interventions & indications

Drugs
Metacognitive Reflection and Insight Therapy (MERIT)

Sponsors

NHS Greater Glasgow and ClydeLead Sponsor
University of GlasgowCollaborator

Investigators

1
Hamish McLeod, PhD CPsycholPrincipal Investigator

Sites

1 total
Glasgow, United Kingdom

Facts & assertions

4 sourced
Enrollment
8
Phase
NA
Primary Completion Date
2020-04
Status
UNKNOWN
relationships
The graph out of here
drug
Metacognitive Reflection and Insight Therapy (MERIT)
drug
lead_sponsor
NHS Greater Glasgow and Clyde
company
collaborator
University of Glasgow
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Hamish McLeod, PhD CPsychol
person